Zhichong Wu

Ruijin Hospital, Shanghai Jiao Tong University

Papers

7

Total Citations

197

H-Index

7

About

Dr. Zhichong Wu is a pioneering surgeon whose work has redefined the landscape of pancreatic surgery through the application of robotic technology. His primary research focuses on minimally invasive pancreatic resections, particularly robotic enucleation and middle pancreatectomy for benign and borderline tumors. Dr. Wu’s major contributions include demonstrating the safety and feasibility of robotic enucleation as a parenchyma-sparing alternative to conventional pancreatectomy, significantly reducing the risk of endocrine and exocrine insufficiency. His landmark studies, such as the randomized controlled trial comparing robot-assisted laparoscopic to open middle pancreatectomy (50 citations) and the large-scale analysis of robotic enucleation (55 citations), have provided critical evidence supporting the adoption of these techniques. He has also advanced the treatment of complex cases, including solid pseudopapillary tumors in the pancreatic head and pancreatic ductal adenocarcinoma, with his work on internal hernia after robotic pancreaticoduodenectomy highlighting his attention to rare but serious complications. With over 200 cumulative citations, Dr. Wu’s research has established him as a leading authority in robotic pancreatic surgery, shaping best practices and improving outcomes for patients worldwide.

Research Focus

Key Achievements

7
H-Index
7
Papers
197
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Enucleation for Benign or Borderline Tumours of the Pancreas: A Retrospective Analysis and Comparison from a High‐Volume Centre in Asia
55 citations · 2016
📈 Most Prolific Year: 2015 (3 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Ruijin Hospital, Shanghai Jiao Tong University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago